Journal article
Noninferiority Randomized Controlled Trials
Abstract
From 2005 to 2015, the publication of noninferiority trials increased by six-fold. Noninferiority trials assess whether a new treatment's efficacy is comparable with that of the standard of care and have several appeals. Noninferiority trials can evaluate for both noninferiority and superiority of a new treatment. In addition, multiple treatment modalities exist, and new treatments may be advantageous for reasons beyond efficacy. Common …
Authors
Kim KS; Chan A-W; Belley-Côté EP; Drucker AM
Journal
Journal of Investigative Dermatology, Vol. 142, No. 7, pp. 1773–1777
Publisher
Elsevier
Publication Date
July 2022
DOI
10.1016/j.jid.2022.04.015
ISSN
0022-202X